Joshua Fleishman
Analyst
on behalf of Ritu Baral)
Equibles does not estimate personal net worth.
About Joshua Fleishman
Joshua Fleishman is recorded as Analyst at on behalf of Ritu Baral). Joshua Fleishman has spoken on 1 earnings call across 1 company, most recently for Palvella Therapeutics, Inc. on May 7, 2026. The companies whose calls Joshua Fleishman spoke on are classified in the Healthcare sector.
Joshua Fleishman on recent calls
“This is Josh Fleischman on the call for a two. Thanks for taking our question. Congrats on initiating the phase two LOTU trial in angiokeratomas. I'm curious, how are the global assessment endpoints and disease severity scales both similar to and potentially different from those used in Selva and TOEVA?”
Affiliation history
-
on behalf of Ritu Baral)
Analyst
Source not stated
Current